This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Takashi Sato, PhD
Chief Scientist & Technical Architect, Life Science Product Division at Rigaku Corporation
Speaker

Profile

Dr. Takashi SATO is a Chief Scientist and Technical Architect of the Life Science Product Division of Rigaku Corporation, a long-established company in X-ray analytical instruments, primarily well-known in laboratory protein crystallography and devices for synchrotron beamlines. He is currently leading the R&D of EDT and MAXS technologies for 3D analysis of therapeutic biomolecules to connect the unmet needs of state-of-the-art technology to the fields where it is entirely unfamiliar with the tech. His works are firmly based on the users' point of view with his decades of experience as a university professor and company researcher in protein science, biophysics, organic chemistry, basic biology, and medicinal sciences, especially pathology, physiology, and obstetrics/gynecology.

Agenda Sessions

  • Electron Density Topography (EDT): A Way for On-demand 3D Observation of Therapeutic Molecules in Solution, From Small Proteins up to Delivery Particles

    7:30am